ES2142089T3 - Derivados de quinolein-2(1h)-ona, su preparacion y su aplicacion en terapeutica. - Google Patents
Derivados de quinolein-2(1h)-ona, su preparacion y su aplicacion en terapeutica.Info
- Publication number
- ES2142089T3 ES2142089T3 ES96931112T ES96931112T ES2142089T3 ES 2142089 T3 ES2142089 T3 ES 2142089T3 ES 96931112 T ES96931112 T ES 96931112T ES 96931112 T ES96931112 T ES 96931112T ES 2142089 T3 ES2142089 T3 ES 2142089T3
- Authority
- ES
- Spain
- Prior art keywords
- group
- quinolein
- therapeutics
- derivatives
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
COMPUESTOS DE FORMULA (I) EN LA CUAL A REPRSENTA UN GRUPO 4 (TIENO[3,2 - C]PIRIDIN - 4 - IL)PIPERACIN - 1 - ILO O 4 - (4 FLUOROBENZOIL)PIPERIDIN - 1 IL); R 1 Y R 2 REPRESENTAN, CADA UNO DE FORMA INDEPENDIENTE, UN ATOMO DE HIDROGENO O DE HALOGENO, O UN GRUPO AMINO, HIDROXI, NITRO, CIANO, (C 1 C 6 )ALQUILO, (C 1 - C 6 )ALCOXI, TRIFLUOROMETILO, TRIFLUOROMETOXI, - COOH, - COOR 4 , - CONH 2 , CONHR SUB,4 , - CONR 4 R 5 , - SR 4 , SO 2 R 4 , - NHCOR 4 , - NHSO 2 R 4 , N(R 4 ) 2 , DONDE R 4 Y R 5 SON CADA UNO UN GRUPO (C 1 - C 4 )ALQUILO, R 3 REPRESENTA BIEN UN ATOMO DE HIDROGENO O BIEN UN GRUPO (C 1 - C 4 )ALQUILO, - (CH 2 ) P OH, - (CH 2 ) P NH 2 , (CH 2 ) N COOH, (CH 2 ) N COOR 4 , (CH 2 ) N CONH 2 , - (CH 2 ) N CONHOH, (CH 2 ) P SH, - (CH 2 ) N SO 3 H, (CH 2 ) N SO 2 NH 2 , (CH 2 ) N SO 2 NHR 4 , (CH 2 ) N SO 2 NR 4 R 5 , (CH 2 ) N CONHR 4 , (CH 2 ) N CONR 4 R 5 , (CH 2 ) P NHSO2 , (CH 2 ) P NHCOR 4 , - (CH 2 ) P OCOR4 , DONDE R 4 Y R 5 SON CADA UNO UN GRUPO (C 1 C 4 )ALQUIL, N ES IGUAL A 1, 2, 3 O 4, P ES IGUAL A 2, 3 O 4 Y M ES IGUAL A 2, 3 O 4. APLICACION TERAPEUTICA.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9510815A FR2738822B1 (fr) | 1995-09-15 | 1995-09-15 | Derives de 4-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)quinolein-2(1h)-one, leur preparation et leur application en therapeutique |
| FR9511083A FR2739100B1 (fr) | 1995-09-21 | 1995-09-21 | Derives de 4-(omega-(4-(4-fluorobenzoyl)piperidin-1-yl)- alkyl)quinolein-2(1h)-one, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2142089T3 true ES2142089T3 (es) | 2000-04-01 |
Family
ID=26232206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES96931112T Expired - Lifetime ES2142089T3 (es) | 1995-09-15 | 1996-09-12 | Derivados de quinolein-2(1h)-ona, su preparacion y su aplicacion en terapeutica. |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US5958924A (es) |
| EP (1) | EP0850235B1 (es) |
| JP (1) | JP3335362B2 (es) |
| KR (1) | KR100422850B1 (es) |
| CN (1) | CN1094490C (es) |
| AR (1) | AR003996A1 (es) |
| AT (1) | ATE187172T1 (es) |
| AU (1) | AU715879B2 (es) |
| BG (1) | BG63779B1 (es) |
| BR (1) | BR9610579A (es) |
| CA (1) | CA2228038C (es) |
| CO (1) | CO4750663A1 (es) |
| CZ (1) | CZ288149B6 (es) |
| DE (1) | DE69605430T2 (es) |
| DK (1) | DK0850235T3 (es) |
| EE (1) | EE04116B1 (es) |
| ES (1) | ES2142089T3 (es) |
| GR (1) | GR3032618T3 (es) |
| HK (1) | HK1014868A1 (es) |
| HU (1) | HU222745B1 (es) |
| IL (1) | IL123600A (es) |
| NO (1) | NO323841B1 (es) |
| NZ (1) | NZ318436A (es) |
| PL (1) | PL184808B1 (es) |
| RU (1) | RU2167874C2 (es) |
| SI (1) | SI0850235T1 (es) |
| SK (1) | SK282222B6 (es) |
| TR (1) | TR199800464T1 (es) |
| UA (1) | UA44332C2 (es) |
| WO (1) | WO1997010238A1 (es) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3335362B2 (ja) * | 1995-09-15 | 2002-10-15 | サノフィ―サンテラボ | キノレイン−２（１ｈ）−オン誘導体セロトニンアンタゴニスト |
| FR2761071B1 (fr) * | 1997-03-20 | 1999-12-03 | Synthelabo | Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique |
| FR2761067B1 (fr) * | 1997-03-20 | 1999-04-23 | Synthelabo | Derives de quinolein-2-(1h)-one, leur preparation et leur application en therapeutique |
| FR2797874B1 (fr) * | 1999-08-27 | 2002-03-29 | Adir | Nouveaux derives de la pyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| CN1395575A (zh) | 2000-01-20 | 2003-02-05 | 卫材株式会社 | 新的哌啶化合物及其药物 |
| FR2812548B1 (fr) * | 2000-08-01 | 2002-09-20 | Sanofi Synthelabo | Utilisation de derives de quinolein-2(1h)-one ou un de leurs sels pharmaceutiquement acceptable pour la preparation d'un medicament destine au traitement de l'insuffisance renale |
| GB0420722D0 (en) | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
| TWI320783B (en) | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
| AR059898A1 (es) | 2006-03-15 | 2008-05-07 | Janssen Pharmaceutica Nv | Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2 |
| FR2909670B1 (fr) * | 2006-12-12 | 2010-07-30 | Sanofi Aventis | Derive fluore de quinoleine-2(1h)-one,son procede de preparation et son utilisation comme intermediaire de synthese |
| TW200845978A (en) | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
| AU2008297876B2 (en) | 2007-09-14 | 2011-07-07 | Addex Pharma S.A. | 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones |
| BRPI0816767B8 (pt) | 2007-09-14 | 2021-05-25 | Addex Pharmaceuticals Sa | composto 4-fenil-3,4,5,6-tetra-hidro-2h,1'h-[1,4']bipiridi¬nil-2'-onas 1',3'-dissubstituídas, composição farmacêutica e uso dos mesmos |
| AU2009289784B2 (en) | 2008-09-02 | 2012-03-22 | Addex Pharma S.A. | 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors |
| ES2424393T3 (es) * | 2008-10-02 | 2013-10-01 | Taisho Pharmaceutical Co., Ltd. | Derivado de 7-piperidinalquil-3,4-dihidroquinolona |
| WO2010060589A1 (en) | 2008-11-28 | 2010-06-03 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors |
| MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| US8946205B2 (en) | 2009-05-12 | 2015-02-03 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
| MY161325A (en) | 2009-05-12 | 2017-04-14 | Janssen Pharmaceuticals Inc | 1, 2, 4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders |
| CN103261195B (zh) | 2010-11-08 | 2015-09-02 | 杨森制药公司 | 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途 |
| PL2649069T3 (pl) | 2010-11-08 | 2016-01-29 | Janssen Pharmaceuticals Inc | Pochodne 1,2,4-triazolo[4,3-a]pirydyny i ich zastosowanie jako dodatnich allosterycznych modulatorów receptorów mGluR2 |
| AU2011328203B2 (en) | 2010-11-08 | 2015-03-19 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
| JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
| JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
| KR102461134B1 (ko) | 2014-01-21 | 2022-10-28 | 얀센 파마슈티카 엔.브이. | 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도 |
| UA121965C2 (uk) | 2014-01-21 | 2020-08-25 | Янссен Фармацевтика Нв | Комбінації, які містять позитивні алостеричні модулятори або ортостеричні агоністи метаботропного глутаматергічного рецептора 2 підтипу, та їх застосування |
| JP6974331B2 (ja) | 2016-02-05 | 2021-12-01 | デナリ セラピューティクス インコーポレイテッドDenali Therapeutics Inc. | 化合物、組成物及び方法 |
| HUE058802T2 (hu) | 2016-12-09 | 2022-09-28 | Denali Therapeutics Inc | RIPK1 inhibitorokként alkalmas vegyületek |
| CN108707109A (zh) * | 2018-08-29 | 2018-10-26 | 常州沃腾化工科技有限公司 | 一种2-甲氧基-4-三氟甲基吡啶-3-磺酰氯的制备方法 |
| AU2023206890A1 (en) | 2022-01-12 | 2024-08-22 | Denali Therapeutics Inc. | Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1278792C (en) * | 1985-05-06 | 1991-01-08 | Joseph P. Yevich | Antipsychotic fused-ring pyridinylpiperazine derivatives |
| KR910006138B1 (ko) * | 1986-09-30 | 1991-08-16 | 에자이 가부시끼가이샤 | 환상아민 유도체 |
| FR2644786B1 (fr) * | 1989-03-21 | 1993-12-31 | Adir Cie | Nouveaux derives fluoro-4 benzoiques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
| JP3335362B2 (ja) * | 1995-09-15 | 2002-10-15 | サノフィ―サンテラボ | キノレイン−２（１ｈ）−オン誘導体セロトニンアンタゴニスト |
-
1996
- 1996-09-12 JP JP51170797A patent/JP3335362B2/ja not_active Expired - Fee Related
- 1996-09-12 AR ARP960104322A patent/AR003996A1/es active IP Right Grant
- 1996-09-12 BR BR9610579A patent/BR9610579A/pt not_active Application Discontinuation
- 1996-09-12 CN CN96198333A patent/CN1094490C/zh not_active Expired - Fee Related
- 1996-09-12 TR TR1998/00464T patent/TR199800464T1/xx unknown
- 1996-09-12 UA UA98031235A patent/UA44332C2/uk unknown
- 1996-09-12 KR KR10-1998-0701920A patent/KR100422850B1/ko not_active IP Right Cessation
- 1996-09-12 CA CA002228038A patent/CA2228038C/en not_active Expired - Fee Related
- 1996-09-12 NZ NZ318436A patent/NZ318436A/xx not_active IP Right Cessation
- 1996-09-12 IL IL12360096A patent/IL123600A/en not_active IP Right Cessation
- 1996-09-12 ES ES96931112T patent/ES2142089T3/es not_active Expired - Lifetime
- 1996-09-12 DE DE69605430T patent/DE69605430T2/de not_active Expired - Lifetime
- 1996-09-12 CZ CZ1998786A patent/CZ288149B6/cs not_active IP Right Cessation
- 1996-09-12 EE EE9800089A patent/EE04116B1/xx not_active IP Right Cessation
- 1996-09-12 EP EP96931112A patent/EP0850235B1/fr not_active Expired - Lifetime
- 1996-09-12 RU RU98106501/04A patent/RU2167874C2/ru not_active IP Right Cessation
- 1996-09-12 PL PL96325467A patent/PL184808B1/pl not_active IP Right Cessation
- 1996-09-12 AU AU69919/96A patent/AU715879B2/en not_active Ceased
- 1996-09-12 SK SK346-98A patent/SK282222B6/sk not_active IP Right Cessation
- 1996-09-12 HU HU9802940A patent/HU222745B1/hu not_active IP Right Cessation
- 1996-09-12 US US09/011,482 patent/US5958924A/en not_active Expired - Lifetime
- 1996-09-12 SI SI9630151T patent/SI0850235T1/xx unknown
- 1996-09-12 DK DK96931112T patent/DK0850235T3/da active
- 1996-09-12 AT AT96931112T patent/ATE187172T1/de active
- 1996-09-12 CO CO96048698A patent/CO4750663A1/es unknown
- 1996-09-12 WO PCT/FR1996/001401 patent/WO1997010238A1/fr active IP Right Grant
-
1998
- 1998-03-11 BG BG102316A patent/BG63779B1/bg unknown
- 1998-03-13 NO NO19981141A patent/NO323841B1/no not_active IP Right Cessation
- 1998-12-30 HK HK98119241A patent/HK1014868A1/xx not_active IP Right Cessation
-
2000
- 2000-02-09 GR GR20000400317T patent/GR3032618T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2142089T3 (es) | Derivados de quinolein-2(1h)-ona, su preparacion y su aplicacion en terapeutica. | |
| EA199700209A1 (ru) | ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-a]ПИРИДИНА | |
| NO965125L (no) | Heterosykliske forbindelser med tachykininreseptor-antagonistaktivitet, deres fremstilling og anvendelse | |
| EA199800908A1 (ru) | Производные индола, полезные в качестве антагонистов рецептора эндотелина | |
| PT856001E (pt) | Derivados de pirimidina enquanto antagonistas do receptor 5ht2c | |
| BG103560A (en) | Quinoline and quinazoline compounds applicable in medicine, in particular for the treatment of benignant prostate hyperplasia | |
| TR199900308T2 (xx) | Tiyenopirimidinler | |
| NO20001624L (no) | Tablettformulering med vedvarende frigivelse for behandling av Parkinsons sykdom | |
| NO941679D0 (no) | Gallesyrederivater, fremgangsmåte for fremstilling og deres anvendelse | |
| EP1140066A4 (en) | NITRO- AND NITROSYL COMPOUNDS OF H2 RECEPTOR ANTAGONISTS, COMPOSITIONS AND THEIR USES OF USE | |
| RU98106501A (ru) | Производные-хинолин-2(1н)-она в качестве антагонистов серотонина | |
| LV12260A (lv) | Piridazino [4,5-b]-hinolina-5-oksida atvasinajumi to iegusana un to izmantosana par glicina antagonistiem | |
| UA49089C2 (uk) | Похідні вуглеводів та фармацевтична композиція на їх основі | |
| AR031196A1 (es) | Procedimiento para la preparacion de ciclopenta (b) (1,4)-diazepino (6,7,1-hi) indoles y derivados | |
| PL331740A1 (en) | Derivatives of acylamino alkenylamide as nk1 and nk2 antagonists | |
| EE200200185A (et) | NK1 retseptori antagonisti ja GABA struktuurse analoogi sünergistilised kombinatsioonid | |
| ATE90348T1 (de) | Pyrido(2,3-d>pyrimidin-derivate. | |
| ES531793A0 (es) | Un procedimiento para la preparacion de nuevos derivados de triazina. | |
| TR200001941T1 (tr) | TNF ve PDE-IV önleyici aktiviteye sahip heterosiklik bileşiklerin N-oksitleri. | |
| DK1025101T3 (da) | Naphtho-imidazo[1,2-a]pyridinderivater, deres fremstilling og deres anvendelse ved behandlingen af sygdomme i centralnervesystemet | |
| KR880005134A (ko) | 인돌로-피라지노-벤조 디아제민 유도체 | |
| MC1784A1 (fr) | Derives tricycliques de la pyridone | |
| DE69617420D1 (de) | 2-substituierte benzimidazolderivate als inhibitoren der glatten muskelzellenproliferation | |
| AR023548A1 (es) | Derivados de 2-alcoxi-ciclobuten-3,4-diona, su preparacion y su aplicacion en terapeutica | |
| TR200003572T2 (tr) | Siyanoiminokuinoksalin Türevleri |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 850235 Country of ref document: ES |